4
Changes in Ownership
Protalix BioTherapeutics, Inc. Filed Acc 0001144204-14-064729
Options or other derivatives
- President & CEO acquired 900,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Manor Moshe President & CEO | 2014-09-29 | Grant or award · Stock Options (Right to Buy) | +900,000 | 900,000 | D | ||
Loading xslF345X03/v392999_4.xml…